Literature DB >> 16601680

Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter.

Céline Tréand1, Isaure du Chéné, Vanessa Brès, Rosemary Kiernan, Richard Benarous, Monsef Benkirane, Stéphane Emiliani.   

Abstract

Activation of the human immunodeficiency virus type-1 (HIV-1) promoter in infected cells requires the sequential recruitment of several cellular factors to facilitate the formation of a processive elongation complex. The nucleosomal reorganization of the HIV-1 long terminal repeat (LTR) observed upon Tat stimulation suggests that chromatin-remodeling complexes could play a role during this process. Here, we reported that Tat interacts directly with Brm, a DNA-dependent ATPase subunit of the SWI/SNF chromatin-remodeling complex, to activate the HIV-1 LTR. Inhibition of Brm via small interfering RNAs impaired Tat-mediated transactivation of an integrated HIV-1 promoter. Furthermore, Brm is recruited in vivo to the HIV-1 LTR in a Tat-dependent manner. Interestingly, we found that Tat/Brm interaction is regulated by Tat lysine 50 acetylation. These data show the requirement of Tat-mediated recruitment of SWI/SNF chromatin-remodeling complex to HIV-1 promoter in the activation of the LTR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16601680      PMCID: PMC1440843          DOI: 10.1038/sj.emboj.7601074

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  55 in total

1.  Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity.

Authors:  M Ott; M Schnölzer; J Garnica; W Fischle; S Emiliani; H R Rackwitz; E Verdin
Journal:  Curr Biol       Date:  1999 Dec 16-30       Impact factor: 10.834

2.  A C/EBP beta isoform recruits the SWI/SNF complex to activate myeloid genes.

Authors:  E Kowenz-Leutz; A Leutz
Journal:  Mol Cell       Date:  1999-11       Impact factor: 17.970

3.  Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro.

Authors:  Y Zhu; T Pe'ery; J Peng; Y Ramanathan; N Marshall; T Marshall; B Amendt; M B Mathews; D H Price
Journal:  Genes Dev       Date:  1997-10-15       Impact factor: 11.361

4.  HIV-1 tat transcriptional activity is regulated by acetylation.

Authors:  R E Kiernan; C Vanhulle; L Schiltz; E Adam; H Xiao; F Maudoux; C Calomme; A Burny; Y Nakatani; K T Jeang; M Benkirane; C Van Lint
Journal:  EMBO J       Date:  1999-11-01       Impact factor: 11.598

5.  Mammalian SWI-SNF complexes contribute to activation of the hsp70 gene.

Authors:  I L de La Serna; K A Carlson; D A Hill; C J Guidi; R O Stephenson; S Sif; R E Kingston; A N Imbalzano
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

6.  Factors associated with the mammalian RNA polymerase II holoenzyme.

Authors:  A S Neish; S F Anderson; B P Schlegel; W Wei; J D Parvin
Journal:  Nucleic Acids Res       Date:  1998-02-01       Impact factor: 16.971

7.  BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer.

Authors:  D A Bochar; L Wang; H Beniya; A Kinev; Y Xue; W S Lane; W Wang; F Kashanchi; R Shiekhattar
Journal:  Cell       Date:  2000-07-21       Impact factor: 41.582

8.  Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription.

Authors:  M Zhou; M A Halanski; M F Radonovich; F Kashanchi; J Peng; D H Price; J N Brady
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

9.  Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation.

Authors:  C Van Lint; S Emiliani; M Ott; E Verdin
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

10.  A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor.

Authors:  C Muchardt; M Yaniv
Journal:  EMBO J       Date:  1993-11       Impact factor: 11.598

View more
  94 in total

1.  The viral protein Tat can inhibit the establishment of HIV-1 latency.

Authors:  Daniel A Donahue; Björn D Kuhl; Richard D Sloan; Mark A Wainberg
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

2.  Characterization of HIV Tat modifications using novel methyl-lysine-specific antibodies.

Authors:  Sara Pagans; Naoki Sakane; Martina Schnölzer; Melanie Ott
Journal:  Methods       Date:  2010-07-06       Impact factor: 3.608

3.  Histonedeacetylase inhibitor Oxamflatin increase HIV-1 transcription by inducing histone modification in latently infected cells.

Authors:  Hao Yin; Yuhao Zhang; Xin Zhou; Huanzhang Zhu
Journal:  Mol Biol Rep       Date:  2010-12-23       Impact factor: 2.316

Review 4.  Functional roles of HIV-1 Tat protein in the nucleus.

Authors:  Yana R Musinova; Eugene V Sheval; Carla Dib; Diego Germini; Yegor S Vassetzky
Journal:  Cell Mol Life Sci       Date:  2015-10-27       Impact factor: 9.261

5.  Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latency.

Authors:  Young Kyeung Kim; Cyril F Bourgeois; Richard Pearson; Mudit Tyagi; Michelle J West; Julian Wong; Shwu-Yuan Wu; Cheng-Ming Chiang; Jonathan Karn
Journal:  EMBO J       Date:  2006-07-27       Impact factor: 11.598

6.  Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency.

Authors:  Isaure du Chéné; Euguenia Basyuk; Yea-Lih Lin; Robinson Triboulet; Anna Knezevich; Christine Chable-Bessia; Clement Mettling; Vincent Baillat; Jacques Reynes; Pierre Corbeau; Edouard Bertrand; Alessandro Marcello; Stephane Emiliani; Rosemary Kiernan; Monsef Benkirane
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

7.  CBF-1 promotes transcriptional silencing during the establishment of HIV-1 latency.

Authors:  Mudit Tyagi; Jonathan Karn
Journal:  EMBO J       Date:  2007-11-15       Impact factor: 11.598

Review 8.  Integration site selection by retroviral vectors: molecular mechanism and clinical consequences.

Authors:  René Daniel; Johanna A Smith
Journal:  Hum Gene Ther       Date:  2008-06       Impact factor: 5.695

Review 9.  Epigenetics, drugs of abuse, and the retroviral promoter.

Authors:  Jasmine Shirazi; Sonia Shah; Divya Sagar; Michael R Nonnemacher; Brian Wigdahl; Zafar K Khan; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2013-11-12       Impact factor: 4.147

10.  Tat controls transcriptional persistence of unintegrated HIV genome in primary human macrophages.

Authors:  Beatrix Meltzer; Deemah Dabbagh; Jia Guo; Fatah Kashanchi; Mudit Tyagi; Yuntao Wu
Journal:  Virology       Date:  2018-03-15       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.